Editorials NSAIDs and atrial fibrillation BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d2495 (Published 04 July 2011) Cite this as: BMJ 2011;343:d2495 Article Related content Metrics Responses Peer review Related articles Research Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study Published: 04 July 2011; BMJ 343 doi:10.1136/bmj.d3450 See more Semaglutide’s CVD indication could cost US Medicare $145bn extra a year BMJ August 28, 2024, 386 q1878; DOI: https://doi.org/10.1136/bmj.q1878 Semaglutide: UK regulator approves drug for prevention of cardiovascular events BMJ July 25, 2024, 386 q1660; DOI: https://doi.org/10.1136/bmj.q1660 Why India is failing to track heatstroke fatalities properly BMJ July 17, 2024, 386 q1437; DOI: https://doi.org/10.1136/bmj.q1437 Mail on Sunday articles that accused three commentators of being “statin deniers” were misinformed, judge rules BMJ June 26, 2024, 385 q1424; DOI: https://doi.org/10.1136/bmj.q1424 Sixty seconds on . . . flying BMJ June 10, 2024, 385 q1266; DOI: https://doi.org/10.1136/bmj.q1266 Cited by... Use of NSAIDs and COX-2 Inhibitors Raises Risk for AFFulltext
